Deca vs NPP, at a glance

People compare Deca and NPP for muscle gain, joint comfort and how long an injection keeps releasing. Both deliver nandrolone; the main difference is the release profile.

A faster profile does not establish better gains or fewer side effects. Joint comfort, muscle growth and natural testosterone production are separate questions.

Compare timing in the plotter Doses & duration

Deca

Nandrolone decanoate

Later, more prolonged release

NPP

Nandrolone phenylpropionate

Earlier, shorter profile

Same active steroid: nandrolone

In a single-injection human comparison, both suppressed natural testosterone. Shorter release is not a safety ranking.

Human comparison: Minto et al.. The plot uses separate single-dose estimates from the 1 mL Deca and 4 mL NPP groups. Curve differences reflect both ester and formulation; this is not a combined regimen.

Reported doses and treatment examples

These are reported male bodybuilding amounts collected from online material, not prescriptions or established safe ranges:

200–600 mg/week

Deca: total per week

The source table does not establish an injection split or cycle length.

300–400 mg/week

NPP: total per week

The source table does not establish an injection split or cycle length.

Mullen et al. compiled user reports and supplier information. Weekly totals are not per-injection amounts. These reports do not tell us a safe course length.

The human release study below used one 100 mg intramuscular injection of either ester, followed for 32 days. That is a research example, not a cycle.

What the human release study found

Minto and colleagues studied 23 healthy men. The direct Deca/NPP comparison used the same injection site and volume; NPP peaked earlier and had a shorter profile. Other Deca groups tested different sites and volumes, which also affected exposure. Minto et al., 1997

This explains why “same steroid” does not mean identical timing. It does not establish an ideal repeated-dose schedule.

A separate human decanoate study measured blood concentrations and urinary markers after a single injection. Its design is a useful reminder that blood pharmacokinetics and urine detection are different measurements. Bagchus et al., 2005

Does nandrolone repair joints?

Less pain does not mean a joint has healed. A small Deca pilot in men already receiving testosterone reported improved joint pain among some respondents. Here is who was followed:

48

Started the study

Men already receiving prescribed testosterone treatment.

18

Returned follow-up

Thirty did not provide follow-up responses.

13

Reported marked improvement

Among those 18 respondents—not among all 48 enrolled.

There was no placebo group, and the median observed treatment period was 62 days. The study assessed pain, not cartilage or tendon repair. It cannot tell us which ester is better for joint comfort or whether training through an injury is safe. Joint-pain pilot

Does a 19-nor steroid mean high prolactin?

No automatic treatment rule follows from that chemical family. Sexual symptoms or breast symptoms alone cannot identify prolactin as the cause. Cabergoline treats specific hyperprolactinemic disorders and has its own risks; it should not be treated as a compulsory companion to nandrolone. Dostinex prescribing information

A clinically useful assessment considers symptoms, measured prolactin, other medicines and possible causes of an abnormal result. Read the cabergoline guide before equating a drug nickname with a diagnosis.

What can the plot help with?

The plotter can help explain timing, overlap and why exposure continues after the last injection. It cannot identify a safe level of suppression or a date to start recovery medication.

Open the Deca/NPP timing comparison →

The example plots a separate single 100 mg ester input for each compound, with a six-week viewing window extending beyond the study’s 32-day follow-up. These are concentration estimates reconstructed from study endpoints. The catalog uses a 1 mL Deca group and a 4 mL NPP group, so differences in curve shape and height cannot be attributed to the ester alone. They are not individual blood-test predictions or proof of dose equivalence. Equal ester mass is also not exactly equal active-steroid mass.

For the individual assumptions, see Deca’s guide and NPP’s guide.

Common questions

Is NPP safer than Deca? Faster release does not remove the active steroid’s effects. This evidence establishes a timing difference, not a universal safety ranking.

Can joint-pain relief mean an injury has healed? No. Pain and tissue healing are different outcomes.

When does natural production recover? An ester-decay estimate cannot establish that. Symptoms, hormone testing and fertility goals need separate assessment; see PCT fundamentals.

Sources and review notes

Checked October 11, 2026. Reported-use amounts, clinical research examples and estimated plotter illustrations serve different purposes.